Hemodynamic support with percutaneous devices in patients with heart failure

Heart Fail Clin. 2015 Apr;11(2):215-30. doi: 10.1016/j.hfc.2014.12.012. Epub 2015 Feb 21.

Abstract

The use of surgically implanted durable mechanical circulatory support (MCS) in high-risk patients with heart failure is declining and short-term, nondurable MCS device use is growing. Percutaneously delivered MCS options for advanced heart failure include the intra-aortic balloon pump, Impella axial flow catheter, TandemHeart centrifugal pump, and venoarterial extracorporeal membrane oxygenation. Nondurable MCS devices have unique implantation characteristics and hemodynamic effects. Algorithms and guidelines for optimal nondurable MCS device selection do not exist. Emerging technologies and applications will address the need for improved left ventricular unloading using lower-profile devices, longer-term ambulatory support, and the potential for myocardial recovery.

Keywords: Assist device; Cardiogenic shock; Decompensated heart failure; ECMO; Impella; Percutaneous mechanical support; Refractory heart failure; TandemHeart.

Publication types

  • Review

MeSH terms

  • Assisted Circulation* / instrumentation
  • Assisted Circulation* / methods
  • Extracorporeal Membrane Oxygenation* / instrumentation
  • Extracorporeal Membrane Oxygenation* / methods
  • Health Services Needs and Demand
  • Heart Failure* / complications
  • Heart Failure* / physiopathology
  • Heart Failure* / therapy
  • Heart Ventricles / physiopathology
  • Heart-Assist Devices*
  • Hemodynamics
  • Humans
  • Shock, Cardiogenic / etiology
  • Shock, Cardiogenic / physiopathology
  • Shock, Cardiogenic / prevention & control*
  • Ventricular Function, Left